Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | CA9 | Q16790 | 3/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | SCN1A | P35498 | 1/20 | 0.31 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.31 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23495570 | 1.00 | HCAR2 (0.38) | HCAR2EPHX1CA12CA1CA2 | |
| SCHEMBL21061211 | 1.00 | HCAR2 (0.38) | HCAR2EPHX1CA12CA1CA2 | |
| SCHEMBL271977 | 1.00 | HCAR2 (0.38) | HCAR2EPHX1CA12CA1CA2 | |
| SCHEMBL16505569 | 0.98 | HCAR2 (0.39) | HCAR2EPHX1CA12CA1CA2 | |
| SCHEMBL16505570 | 0.98 | HCAR2 (0.39) | HCAR2EPHX1CA12CA1CA2 | |
| SCHEMBL1050591 | 0.90 | HCAR2 (0.47) | HCAR2EPHX1CA12CA1CA2 | |
| SCHEMBL1050594 | 0.90 | HCAR2 (0.47) | HCAR2EPHX1CA12CA1CA2 | |
| SCHEMBL8893827 | 0.85 | EPHX1 (0.38) | HCAR2EPHX1CA12CA1CA2 | |
| SCHEMBL6023045 | 0.84 | HCAR2 (0.60) | HCAR2EPHX1CA12CA1CA2 | |
| SCHEMBL8896991 | 0.82 | EPHX1 (0.34) | HCAR2EPHX1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 511 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441953-B2 | Isomer mixtures of unsaturated macrocyclic musk compounds | SYMRISE AG (DE) | 2025-10-14 | — | — | US | claimed |
| CN-111051483-B | Esters and ethers of 2, 4-tetramethyl cyclobutane-1, 3-diol as fragrance chemicals | 巴斯夫欧洲公司 | 2025-01-24 | — | — | CN | claimed |
| US-12187978-B2 | Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical | BASF SE (DE) | 2025-01-07 | — | — | US | claimed |
| US-20240173227-A1 | A FRAGRANCE MIXTURE CONTAINING ISOCITRONELLOL | SYMRISE AG (DE) | 2024-05-30 | — | — | US | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| EP-2430140-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2012-03-21 | — | — | EP | claimed |
| US-12630781-B2 | Fragrance or flavour mixture | SYMRISE AG (DE) | 2026-05-19 | — | — | US | disclosed |
| US-12625123-B2 | Device and method for the analytical and sensory determination of the release of an active substance from a release system | SYMRISE AG (DE) | 2026-05-12 | — | — | US | disclosed |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | SYMRISE AG (DE) | 2026-04-09 | — | — | US | disclosed |
| EP-4077299-B1 | SUBSTITUTED 4-METHYLENE-TETRAHYDROPYRANS, 4-METHYL-DIHYDROPYRANS AND 4-METHYL-TETRAHYDROPYRANS AND USE THEREOF AS AROMA CHEMICALS | BASF SE (DE) | 2026-04-01 | — | — | EP | disclosed |
| US-12590265-B2 | 1-norbornan-2-ylpropan-2-one as a fragrance | SYMRISE AG (DE) | 2026-03-31 | — | — | US | disclosed |
| US-12583833-B2 | Enrichment of a diastereomer in Magnolan | SYMRISE AG (DE) | 2026-03-24 | — | — | US | disclosed |
| US-20260071137-A1 | 5,5-DISUBSTITUED TETRAHYDROFURAN-2-ONE AS FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2026-03-12 | — | — | US | disclosed |
| WO-2007131834-A1 | TRISUBSTITUTED FURAN DERIVATIVES AS FRAGRANCES AND AROMA SUBSTANCES | SYMRISE GMBH & CO. KG (DE) | 2007-11-22 | — | — | WO | disclosed |
| US-20070254826-A1 | Novel uses of 4-methyl-5-hydroxy-hexanoic acid lactone | SYMRISE GMBH & CO. KG (DE) | 2007-11-01 | — | — | US | disclosed |
| US-20070072789-A1 | 2-Methyl-5-phenylpentanal used as a rose odoriferous substance | SYMRISE GMBH & CO. KG (DE) | 2007-03-29 | — | — | US | disclosed |
| US-20070037733-A1 | Use of 3-cyclohexenyl-1-propanol as a fragrance | SYMRISE GMBH & CO. KG (DE) | 2007-02-15 | — | — | US | disclosed |
| US-20060211597-A1 | Cis-3,3,5-trimethylcyclohexyl esters | SYMRISE AG (DE) | 2006-09-21 | — | — | US | disclosed |
| US-20060166857-A1 | 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes | SYMRISE GMBH & CO. KG (DE) | 2006-07-27 | — | — | US | disclosed |
| US-20060135400-A1 | 4-Cyclohexyl-2-butanol as an odiferous substance | SYMRISE GMBH & CO. KG (DE) | 2006-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583833-B2 | Enrichment of a diastereomer in Magnolan | TRPA1, ENO1, ADH1A | HCAR2 2710/4885EPHX1 425/4885CA12 199/4885 |
| US-12625123-B2 | Device and method for the analytical and sensory determination of the release of an active substance from a release system | TAS2R7, TAS2R42, TAS2R39 | HCAR2 273/4885EPHX1 2373/4885CA12 276/4885 |
| US-12590265-B2 | 1-norbornan-2-ylpropan-2-one as a fragrance | OR10J3, TAS2R40, TAS2R50 | HCAR2 270/4885EPHX1 3365/4885CA12 2947/4885 |
| US-20260071137-A1 | 5,5-DISUBSTITUED TETRAHYDROFURAN-2-ONE AS FRAGRANCE COMPOUNDS | PRMT5, ACSL5, ELOVL5 | HCAR2 540/4885EPHX1 1125/4885CA12 3966/4885 |
| US-12630781-B2 | Fragrance or flavour mixture | NOTUM, FFAR2, FFAR1 | HCAR2 163/4885EPHX1 789/4885CA12 1246/4885 |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | PTGS2, PTGES2, PTGS1 | HCAR2 92/4885EPHX1 236/4885CA12 754/4885 |
| US-20240173227-A1 | A FRAGRANCE MIXTURE CONTAINING ISOCITRONELLOL | IPO5, OR51E2, FDFT1 | HCAR2 2692/4885EPHX1 2321/4885CA12 3671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.